KRYS Form 144: 37,895 Shares Proposed Sale

KRYS submitted a Form 144 notifying a proposed sale of Common stock, listing 37,895 shares to be sold through Fidelity Brokerage Services LLC by 02/24/2026 with a sale method labeled Cash.

Rhea-AI Filing Summary

KRYS submitted a Form 144 notifying a proposed sale of Common stock, listing 37,895 shares to be sold through Fidelity Brokerage Services LLC by 02/24/2026 with a sale method labeled Cash.

The filing also shows securities sold during the past three months: 13,825 Common shares by Daniel S. Janney on 02/24/2026 for $3,709,850.15.

Insights

SEC Filings Analyst

Routine Rule 144 sale notice listing specific share counts and a recent disposal.

The filing lists a proposed sale of 37,895 Common shares through Fidelity Brokerage Services LLC dated 02/24/2026. It records a recent disposition of 13,825 shares by Daniel S. Janney on 02/24/2026 for $3,709,850.15.

As a Rule 144 notice, this is procedural: timing and execution depend on market activity and compliance with Rule 144 conditions. Subsequent filings or trade reports would show completed sales and any cash flows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does KRYS's Form 144 filed 02/24/2026 report?

The Form 144 reports a proposed sale of 37,895 Common shares through Fidelity Brokerage Services LLC with a sale method of Cash dated 02/24/2026. It is a Rule 144 notice of intent to sell restricted or control stock.

How many shares did Daniel S. Janney sell recently according to the filing?

The filing shows 13,825 Common shares sold by Daniel S. Janney on 02/24/2026. The reported sale produced $3,709,850.15 as the dollar amount recorded in the filing.

Who is the broker listed for the proposed sale in KRYS's Form 144?

The broker listed is Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI. The filing connects the proposed transaction to that broker with the 02/24/2026 date.

Does the Form 144 confirm the sale was completed?

No; the Form 144 notifies an intent to sell and lists proposed quantities, such as 37,895 shares. Completion and settlement are not confirmed by this notice; executed trades would appear in trade filings or post-sale disclosures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 05:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001198325
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Krystal Biotech, Inc.
SEC File Number	001-38210
Address of Issuer	2100 WHARTON STREET SUITE 701 PITTSBURGH PENNSYLVANIA 15203
Phone	(412) 586-5830
Name of Person for Whose Account the Securities are To Be Sold	JANNEY DANIEL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	37895	10113354.42	29232189	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2026	Option Granted 11/10/2016	Issuer			37895	02/24/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel S. Janney 2100 Wharton Street, Suite 701 Pittsburgh PA 15203	Common	02/24/2026	13825	3709850.15

144: Remarks and Signature

Remarks
Date of Notice	02/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel S. Janney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)